200 related articles for article (PubMed ID: 35820706)
1. PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.
Tabury K; Monavarian M; Listik E; Shelton AK; Choi AS; Quintens R; Arend RC; Hempel N; Miller CR; Györrfy B; Mythreye K
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35820706
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
Yang Q; Yu Y; Sun Z; Pan Y
Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1.
Liu E; Liu Z; Zhou Y
Int J Clin Exp Pathol; 2015; 8(4):3803-10. PubMed ID: 26097562
[TBL] [Abstract][Full Text] [Related]
4. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
Chen Y; Li F; Li D; Liu W; Zhang L
Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
Qu C; Dai C; Guo Y; Qin R; Liu J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
[TBL] [Abstract][Full Text] [Related]
6. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140.
Ding Y; Fang Q; Li Y; Wang Y
Mamm Genome; 2019 Aug; 30(7-8):217-225. PubMed ID: 31222482
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2.
Zou MF; Ling J; Wu QY; Zhang CX
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7183-7188. PubMed ID: 30468460
[TBL] [Abstract][Full Text] [Related]
8. Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression.
Pan Y; Liu L; Cheng Y; Yu J; Feng Y
Biochem Cell Biol; 2020 Dec; 98(6):676-682. PubMed ID: 33167678
[TBL] [Abstract][Full Text] [Related]
9. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
Sun ZY; Jian YK; Zhu HY; Li B
Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
Xu Q; Lin YB; Li L; Liu J
Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.
Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR
Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196
[TBL] [Abstract][Full Text] [Related]
18. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
Yang J; Li C; Mudd A; Gu X
Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 epigenetically stabilizes and post-transcriptionally regulates FOXM1 by acting as a microRNA sponge and thus promotes malignant behaviors of ovarian cancer cells.
Yi K; Hou M; Yuan J; Yang L; Zeng X; Xi M; Chen J
Am J Transl Res; 2020; 12(6):2860-2874. PubMed ID: 32655815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
